These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9700889)

  • 1. [Intestinal microbiocensosis and immune status in young children with severe forms of acute pneumonia after the use of different therapy regimens].
    Dolgushin II; Ogoshkova IA; Rusanova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (3):69-73. PubMed ID: 9700889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A trial of using a dry bifidobacterin preparation with newborn risk groups to prevent acute intestinal infections].
    Chernysheva NA; Mel'nikova KI; Finkel' MP; Izotova ZB
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):37-9. PubMed ID: 8017124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of bifidumbacterin in young children with acute intestinal diseases].
    Protoklitova NS; Sterligova ND; Naumova MA; Romanov MV
    Vopr Okhr Materin Det; 1977; 22(2):54-8. PubMed ID: 841947
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Pobedinskaia IN; Gevondian VS; Gevondian NM; Mitrokhin SD; Minaev VI; Dzis NB; Makkaveeva LF; Kovalev IV; Murashova AO; Bondarenko VM
    Antibiot Khimioter; 2000; 45(10):22-7. PubMed ID: 11212396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impaired interferon status in children with acute respiratory infection and its correction with bifidumbacterin-forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Murashova AO
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):65-7. PubMed ID: 11548264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The microbiocenosis of the intestines and its influence on the course of postenterocolitic reactive arthritis].
    Rubtsov OV; Bevz NI; Agababova ER; Goncharova GI
    Revmatologiia (Mosk); 1990; (2):46-50. PubMed ID: 2218264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The regulation of microecological disorders of the intestines in newborn infants with perinatal pathology using the new probiotic bifidumbacterin-forte].
    Iakushenko MN; Tkhagapsoeva ZhM; Bondarenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):18-22. PubMed ID: 9460858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The interrelation of the immunity status and intestinal microbiocenosis in young children with acute respiratory organ diseases].
    Kulinin DG; Abaturov AE; Gerasimenko ON; Vernik AG
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):27-9. PubMed ID: 1455963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The probiotic correction of microecological and immune disorders in gastroduodenal pathology in children].
    Lykova EA; Bondarenko VM; Izachik IuA; Izachik NA; Grigor'ev AV; Murashov AO; Abramov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):88-91. PubMed ID: 8701669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of bifidumbacterin for the correction of intestinal dysbacteriosis].
    Liz'ko NN; Goncharova GI
    Kosm Biol Aviakosm Med; 1987; 21(4):70-2. PubMed ID: 3657069
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monkeys as subjects for study of immunobiological preparations].
    Aleshkin VA; Lapin BA; Afanas'ev SS; Pospelova VV; Dzhikidze EK; Afanas'ev MS
    Vestn Ross Akad Med Nauk; 2006; (2):11-5. PubMed ID: 16544898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A method for assessing the efficacy of using bifidumbacterin for the prevention of suppurative-inflammatory diseases in the newborn].
    Cherniatina LF; Berezhnoĭ VF; Tulupova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):36-40. PubMed ID: 2385987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current possibilities and perspectives of the combined treatment of patients with severe bronchopulmonary diseases].
    Sokolova VI; Shenderovich VA; Orlov VA; Elagina LV
    Antibiot Khimioter; 2002; 47(8):16-9. PubMed ID: 12515092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of the eubiotic bifacide when used in the combined antibacterial therapy of newborn infants with infectious-inflammatory diseases].
    Kushnareva MV; Dement'eva GM; Chernonog IN; Frolova MI; Feklisova LV; Rebrova TN
    Antibiot Khimioter; 1996; 41(11):28-32. PubMed ID: 9214283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of bifidumbacterin on microflora of the intestines in preterm children with pneumonia].
    Kozlova EP; Semenova LP; Goncharova GI; Chistiakova VI; Atserova IS
    Pediatriia; 1977 May; (5):48-9. PubMed ID: 876760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience of pediatric application of bifidumbacterin multi, a biologically active food supplement].
    Amerkhanova AM; Lavrova AE; Dmitrieva GV; Pyrikova IA; Zubkova ES; Zhilenkova OG; Kuralenko AA
    Vestn Ross Akad Med Nauk; 2005; (12):30-2. PubMed ID: 16404980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of using bifidokefir for the treatment of acute intestinal infections and for the correction of dysbacterosis in children].
    Murashova AO; Novokshonov AA; Uchaĭkin VF
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):108-10. PubMed ID: 7879497
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of bifidumbacterin in the prevention of mastitis].
    Sytnik SI; Panichev VA; Dautov AG
    Vrach Delo; 1990 Mar; (3):98-100. PubMed ID: 2368375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correction of intestinal dysbacteriosis in elderly patients with the use of bifidobacterin introduced by different routes].
    Chulok TA; Kaverina KG; Shumova SL; Matsulevich TV; Doroshenko EO
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):76-8. PubMed ID: 15188566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.